Suppr超能文献

根据体重减轻程度,动脉粥样硬化风险因素谱的变化。

Changes in the atherogenic risk factor profile according to degree of weight loss.

作者信息

Reinehr T, Andler W

机构信息

Department of Vestische Kinderklinik, University of Witten-Herdecke, Datteln, Germany.

出版信息

Arch Dis Child. 2004 May;89(5):419-22. doi: 10.1136/adc.2003.028803.

Abstract

BACKGROUND

The atherogenic risk factor profile in obese subjects is characterised by hypertension, reduced high density lipoprotein (HDL) cholesterol, increased low density lipoprotein (LDL) cholesterol and triglycerides, and insulin resistance.

AIMS

To examine the amount of weight reduction required to improve the atherogenic profile.

METHODS

Changes of systolic and diastolic blood pressure, HDL and LDL cholesterol, triglycerides, and insulin resistance, based on the HOMA model over a one year period were studied in obese children, who attended the intervention programme "Obeldicks". The children were divided into four groups according to the change in body mass index standard deviation score (SDS-BMI): group I, increase in SDS-BMI; group II, decrease in SDS-BMI <0.25; group III, decrease in SDS-BMI > or =0.25-<0.5; group IV, decrease in SDS-BMI > or =0.5.

RESULTS

A total of 130 children (mean age 10.7 years, range 4-15; mean SDS-BMI 2.5, range 2.0-4.0) were studied. The four groups did not differ in age, gender, or degree of overweight (SDS-BMI). An increasing SDS-BMI (group I: n = 20) was followed by a significant increase in insulin resistance (HOMA). Systolic and diastolic blood pressure, LDL cholesterol, triglycerides, and insulin resistance (HOMA) decreased significantly while HDL cholesterol increased significantly in group IV (n = 37). LDL cholesterol also decreased significantly in group III (n = 40); there was no significant change of the other parameters in groups I, II, and III.

CONCLUSION

Over a time period of one year increasing weight in obese children leads to an increase in insulin resistance. Weight loss is associated with an improvement in the atherogenic profile and in insulin resistance, but only if the SDS-BMI decreases by at least 0.5 over a one year period.

摘要

背景

肥胖受试者的动脉粥样硬化危险因素特征为高血压、高密度脂蛋白(HDL)胆固醇降低、低密度脂蛋白(LDL)胆固醇和甘油三酯升高以及胰岛素抵抗。

目的

研究改善动脉粥样硬化特征所需的体重减轻量。

方法

在参加“Obeldicks”干预项目的肥胖儿童中,基于HOMA模型研究了一年内心脏收缩压和舒张压、HDL和LDL胆固醇、甘油三酯以及胰岛素抵抗的变化。根据体重指数标准差评分(SDS-BMI)的变化将儿童分为四组:第一组,SDS-BMI增加;第二组,SDS-BMI降低<0.25;第三组,SDS-BMI降低≥0.25且<0.5;第四组,SDS-BMI降低≥0.5。

结果

共研究了130名儿童(平均年龄10.7岁,范围4 - 15岁;平均SDS-BMI 2.5,范围2.0 - 4.0)。四组在年龄、性别或超重程度(SDS-BMI)方面无差异。SDS-BMI增加(第一组:n = 20)后,胰岛素抵抗(HOMA)显著增加。第四组(n = 37)的收缩压和舒张压、LDL胆固醇、甘油三酯以及胰岛素抵抗(HOMA)显著降低,而HDL胆固醇显著升高。第三组(n = 40)的LDL胆固醇也显著降低;第一组、第二组和第三组的其他参数无显著变化。

结论

在一年的时间里,肥胖儿童体重增加会导致胰岛素抵抗增加。体重减轻与动脉粥样硬化特征和胰岛素抵抗的改善相关,但前提是SDS-BMI在一年内至少降低0.5。

相似文献

1
Changes in the atherogenic risk factor profile according to degree of weight loss.
Arch Dis Child. 2004 May;89(5):419-22. doi: 10.1136/adc.2003.028803.
2
Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?
J Clin Endocrinol Metab. 2016 Aug;101(8):3171-9. doi: 10.1210/jc.2016-1885. Epub 2016 Jun 10.
3
Insulin sensitivity among obese children and adolescents, according to degree of weight loss.
Pediatrics. 2004 Dec;114(6):1569-73. doi: 10.1542/peds.2003-0649-F.
7
Changes in lipidemia during chronic care treatment of childhood obesity.
Child Obes. 2012 Dec;8(6):533-41. doi: 10.1089/chi.2011.0098.
10
Prognostic Value of the Modified Atherogenic Index of Plasma during Body Mass Reduction in Polish Obese/Overweight People.
Int J Environ Res Public Health. 2018 Dec 27;16(1):68. doi: 10.3390/ijerph16010068.

引用本文的文献

2
3
Effectiveness of Smartphone App for the Treatment of Pediatric Obesity: A Randomized Controlled Trial.
Children (Basel). 2024 Sep 27;11(10):1178. doi: 10.3390/children11101178.
4
Effectiveness of utilizing step-monitoring devices to prevent and treat obesity in children and adolescents: A systematic review and meta-analysis.
Digit Health. 2024 Aug 14;10:20552076241272589. doi: 10.1177/20552076241272589. eCollection 2024 Jan-Dec.
6
Current and future state of pharmacological management of pediatric obesity.
Int J Obes (Lond). 2025 Mar;49(3):388-396. doi: 10.1038/s41366-024-01465-y. Epub 2024 Feb 6.
7
Long-term effects of 12-month integrated weight-loss programme for children with excess body weight- who benefits most?
Front Endocrinol (Lausanne). 2023 Nov 3;14:1221343. doi: 10.3389/fendo.2023.1221343. eCollection 2023.
8
Obesity in children and adolescents: Overview of the diagnosis and management.
Chronic Dis Transl Med. 2023 Mar 7;9(2):122-133. doi: 10.1002/cdt3.58. eCollection 2023 Jun.
9
Cardiometabolic risk factors among children who are affected by overweight, obesity and severe obesity.
Front Public Health. 2023 Apr 27;11:1097675. doi: 10.3389/fpubh.2023.1097675. eCollection 2023.
10

本文引用的文献

1
Predictors to success in outpatient training in obese children and adolescents.
Int J Obes Relat Metab Disord. 2003 Sep;27(9):1087-92. doi: 10.1038/sj.ijo.0802368.
2
Long-term follow-up of overweight children: after training, after a single consultation session, and without treatment.
J Pediatr Gastroenterol Nutr. 2003 Jul;37(1):72-4. doi: 10.1097/00005176-200307000-00013.
3
The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation.
Eur J Pediatr. 2003 Jun;162(6):421-5. doi: 10.1007/s00431-003-1181-3. Epub 2003 Mar 15.
4
Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials.
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):66-75. doi: 10.1111/j.1524-6175.2003.01307.x.
5
Effects of the amount and intensity of exercise on plasma lipoproteins.
N Engl J Med. 2002 Nov 7;347(19):1483-92. doi: 10.1056/NEJMoa020194.
7
Childhood obesity: public-health crisis, common sense cure.
Lancet. 2002 Aug 10;360(9331):473-82. doi: 10.1016/S0140-6736(02)09678-2.
8
Effects of dietary intervention and strength training on blood lipid level in obese children.
Arch Dis Child. 2002 Jun;86(6):407-10. doi: 10.1136/adc.86.6.407.
10
Insulin resistance as a predictor of age-related diseases.
J Clin Endocrinol Metab. 2001 Aug;86(8):3574-8. doi: 10.1210/jcem.86.8.7763.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验